Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies

• Published in: Journal of controlled release 2023-03, Vol.355, p.292-311
• Main Authors: Gaikwad, Sachin S., Pathare, Snehal R., More, Mayur A., Waykhinde, Nikita A., Laddha, Umesh D., Salunkhe, Kishor S., Kshirsagar, Sanjay J., Patil, Sakshi S., Ramteke, Kuldeep H.
• Format: Article
• Language: English
• Subjects: Administration, Inhalation; Artificial neural networks; Asthma; COPD; COVID-19; DPI; Dry Powder Inhalers; Humans; Liposomes; Metal Nanoparticles; Nanoparticle; Powders; Silver
• ISSN: 0168-3659; 1873-4995
• DOI: 10.1016/j.jconrel.2023.01.083

A Dry Powder Inhaler (DPI) is a technique as well as a device used to inhale formulation which is in the form of dry powder, and is inhaled through the nose or mouth. It was developed for the purpose of treating conditions like chronic obstructive pulmonary disease (COPD), Asthma, and even cystic fibrosis etc. The aim of the review is to discuss the different methods of preparation of dry powders along with the characterization of DPI. Here we present the outline of different methods like supercritical fluid extraction (SCF), spray drying, and milling. The review focussed on various devices including single and multi-dose devices used in the DPI. It also highlights on recent advances in the DPI including nano particulate system, siRNA-based medication, liposomes, and pro-liposomes based delivery. In COVID-19 silver nanoparticles-based DPIs provide very prominent results in the infected lungs. Moreover, this review states that the AI-based DPI development provides and improvement in the bioavailability and effectiveness of the drug along with the role of artificial neural networks (ANN). The study also showed that nasally administered drugs (nose to brain) can easily cross the blood-brain barrier (BBB) and enter the central nervous system (CNS) through the olfactory and trigeminal pathway which provides effective CNS concentrations at lower dosage. It is suggested that DPIs not only target respiratory complications but also treat CNS complications too. This review provides support and guides the researcher in the recent development and evaluation of DPI. [Display omitted] •Majority of population is suffering from various types of respiratory diseases.•The most used way for treating respiratory illnesses is DPI.•Use of DPI during the COVID-19 pandemic.•DPI demonstrated positive outcomes when delivering medications for systemic effects.•DPI with nanotechnology is new hope for the treatment of respiratory disorders.